Regulation And Legal
Vaishali Pharma Promoter Nil Encumbrance Disclosure FY2026
Vaishali Pharma filed Annual Disclosure under SEBI Takeover Regulations 31(4) for FY ended 31st March 2026.
Promoter & Chairman Atul Arvindbhai Vasani confirmed zero encumbrance on shares by Promoter
